Publications

Latest publication 05/07/2026

Functional ECM Hydrogel for Targeted Delivery of bFGF and Angiopoietin-1 Mimetic

Ischemic stroke (IS) remains a major cause of global disability and mortality. Currently, neuroprotection, angiogenesis, and repair of injured...

Array
(
    [id_prestablog_news] => 2550
    [id_shop] => 1
    [date] => 2026-05-07 00:00:00
    [date_modification] => 2026-05-07 00:00:00
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [ishero] => 0
    [prim_key] => 4967
    [id_lang] => 1
    [title] => Functional ECM Hydrogel for Targeted Delivery of bFGF and Angiopoietin-1 Mimetic
    [paragraph] => Functional ECM Hydrogel for Targeted Delivery of bFGF and Angiopoietin-1 Mimetic Peptide Enhances Neurovascular Regeneration in Ischemic Stroke | ACS Applied Bio Materials
    [content] => 
Authors
Li  Wang, Qi  Liu, Hui  Yang, Chen  Jiang, Yiying  Sun, Zhuo  Liu, Haiping  Wang, Chunying  Shi

Lab
Brought to you by ACS Institute
Journal
ACS Applied Bio Materials
Abstract
Ischemic stroke (IS) remains a major cause of global disability and mortality. Currently, neuroprotection, angiogenesis, and repair of injured blood brain barrier (BBB) are common regenerative therapy strategies for IS. The primary challenge remains how to integrate these processes into a synergistic tissue repair program in response to microenvironmental cues. In the present study, a functional ECM hydrogel was constructed by combining with specific ECM-binding bFGF (EBP-bFGF) for neuroprotection and chemically modifying with a matrix metalloproteinase-2 (MMP-2)-cleavable motif to control the release of angiopoietin-1 mimetic peptide (AMP), thereby promoting angiogenesis and BBB repair. After verification of the biological activityin vitro, the EBP-bFGF/ECM/TIMP-AMP hydrogel was transplanted into ischemic brain following IS. The findings indicated that the application of the innovative EBP-bFGF/ECM/TIMP-AMP hydrogel facilitated the preservation of neuronal integrity and conferred potent neuroprotection. Additionally, the therapeutic intervention significantly stimulated angiogenesis and achieved stabilization of the blood brain barrier through inhibition of MMP-2 overactivity, thereby diminishing vascular permeability. Collectively, these findings establish the targeted, stimulus-responsive co-delivery of bFGF and TIMP-AMP as a promising regenerative strategy, which orchestrates neuroprotection, angiogenesis, and BBB stabilization to synergistically promote repair and recovery after ischemic stroke.
Keywords/Topics
ischemic stroke; extracellular matrix hydrogel; controlled release; blood brain barrier; angiopoietin-1 mimetic peptide
    [meta_description] => 
    [meta_keywords] => https://pubs.acs.org/doi/abs/10.1021/acsabm.5c02567
    [meta_title] => 
    [link_rewrite] => Functional-ECM-Hydrogel-for-Targeted-Delivery-of-bFGF-and-Angiopoietin-1-Mimetic-Peptide-Enhances-Neurovascular-Regeneration-in-Ischemic-Stroke-|-ACS-Applied-Bio-Materials
    [actif_langue] => 1
    [read] => 0
    [count_comments] => 0
    [id] => 2550
    [categories] => Array
        (
            [40] => Array
                (
                    [id_prestablog_categorie] => 40
                    [title] => Ischemic Strokes
                    [link_rewrite] => Ischemic-Strokes
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Functional ECM Hydrogel for Targeted Delivery of bFGF and Angiopoietin-1 Mimetic Peptide [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [48] => Array
                (
                    [name] => Grip strength test
                    [description_short] => 
An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.
New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html
                )

        )

)
1